15A Shiraji Nagtur, India

Shriran Netke

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shriran Netke. Retrieved from https://idiyas.com/inventor/shriran-netke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shriran Netke: Innovator in Neoplastic Disease Treatment

Introduction

Shriran Netke is a notable inventor based in Nagtur, India. He has made significant contributions to the field of medical science, particularly in the treatment of neoplastic diseases. His innovative approach combines various compounds to enhance therapeutic efficacy.

Latest Patents

Shriran Netke holds a patent for a composition and method for the treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds. The patent describes a composition that includes a catechin compound, ascorbic acid, proline, and lysine. This invention aims to provide an effective method for treating neoplastic diseases by utilizing these specific compounds.

Career Highlights

Throughout his career, Shriran has focused on developing solutions that address complex medical challenges. His work has been recognized for its potential impact on cancer treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Shriran has collaborated with notable professionals in his field, including Vadim O Ivanov and Wahid M Roomi. These partnerships have contributed to the advancement of his research and the development of innovative treatment methods.

Conclusion

Shriran Netke's contributions to the treatment of neoplastic diseases highlight his role as a pioneering inventor. His innovative compositions and methods represent a significant step forward in medical science, offering hope for improved therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…